| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,067,000 | 1,121,900 | 1,005,600 | 1,103,800 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 1,121,900 | 1,005,600 | 1,103,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 381,500 | 876,800 | 821,600 | 1,024,200 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 490,000 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 147,600 | 245,100 | 184,000 | 79,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 25,700 | (25,700) |
-
|
-
| | Earnings Before Interest And Taxes | 221,200 | 219,400 | 184,000 | 79,600 | | Interest Expense | 18,500 | 13,400 | 16,000 | 17,700 | | Income Before Tax | 202,700 | 206,000 | 168,000 | 61,900 | | Income Tax Expense | 71,600 | 73,900 | 58,300 | 24,500 | | Minority Interest | (3,900) | (10,700) |
-
| 1,200 | | | | Net Income From Continuing Ops | 141,800 | 121,400 | 109,700 | 38,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 127,200 | 121,400 | 109,700 | 38,600 | | Preferred Stock And Other Adjustments |
-
| 5,900 | (5,900) |
-
| | | Net Income Applicable To Common Shares | $127,200 | $127,300 | $103,800 | $38,600 |
|
0.51% Nasdaq 
Income Statement
